UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by AlphaStar Capital Management LLC

AlphaStar Capital Management LLC grew its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 24.6% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 870 shares of the healthcare conglomerate’s stock after acquiring an additional 172 shares during the period. AlphaStar Capital Management LLC’s holdings in UnitedHealth Group were worth $440,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. AMF Tjanstepension AB lifted its position in shares of UnitedHealth Group by 88.0% during the third quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after purchasing an additional 121,180 shares during the last quarter. Hudson Value Partners LLC increased its holdings in shares of UnitedHealth Group by 8.3% in the 3rd quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after acquiring an additional 82 shares during the last quarter. Wealth Group Ltd. boosted its holdings in UnitedHealth Group by 4.0% in the third quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after purchasing an additional 68 shares during the period. Perfromance Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth $201,000. Finally, Annex Advisory Services LLC grew its position in shares of UnitedHealth Group by 2.7% during the 3rd quarter. Annex Advisory Services LLC now owns 41,955 shares of the healthcare conglomerate’s stock valued at $24,530,000 after buying an additional 1,110 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.6 %

UnitedHealth Group stock opened at $526.68 on Monday. The firm has a market cap of $484.69 billion, a price-to-earnings ratio of 33.98, a price-to-earnings-growth ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm’s 50 day moving average price is $529.18 and its two-hundred day moving average price is $564.37. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. During the same quarter last year, the company posted $5.83 EPS. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently commented on the company. TD Cowen upped their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a report on Friday, October 18th. Oppenheimer increased their target price on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective on the stock in a report on Friday, January 10th. KeyCorp restated an “overweight” rating and issued a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Finally, Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a report on Monday, January 6th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Buy” and a consensus price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.